Youtor
Soho Hematology (updated 2024-09-30)
![Granulocytes amp Tcells as biomarkers for relapse in CML following discontinuation of TKIs [upl. by Liz986]](img.php?img=imgidfg2tpVnzAxg)
Duration: 3:18
54 weergaven | 11 maanden geleden
54 weergaven | 11 maanden geleden
![OPTIMISMM benefits of a new triplet therapy for MM patients relapsing on lenalidomide [upl. by Nahgem]](img.php?img=imgidu1hDyUOB6lw)
Duration: 1:43
72 weergaven | 19 sep. 2018
72 weergaven | 19 sep. 2018
![Improving transplantation outcomes in patients with active AML current approaches amp future outlooks [upl. by Siednarb]](img.php?img=imgidpOIFYfDTD6Q)
Duration: 2:09
100 weergaven | 11 maanden geleden
100 weergaven | 11 maanden geleden
![Challenges in treating patients with HL who relapse after autoSCT amp novel therapies being explored [upl. by Zarihs]](img.php?img=imgidDN5bqBWfR3k)
Challenges in treating patients with HL who relapse after autoSCT amp novel therapies being explored
Duration: 2:10
84 weergaven | 11 maanden geleden
84 weergaven | 11 maanden geleden
![Updates on the management of Hodgkin lymphoma earlystage disease vs advanced stage disease [upl. by Esirahs]](img.php?img=imgidqCutc5sScds)
Duration: 1:40
101 weergaven | 11 maanden geleden
101 weergaven | 11 maanden geleden
![Immunotherapeutic approaches in CALRmutated MPNs [upl. by Dang]](img.php?img=imgidkueY_nxFhC8)
![VENICE II trial healthrelated QoL in patients with CLL treated with venetoclax [upl. by Ede]](img.php?img=imgidrHs86_LnCow)
Duration: 0:49
76 weergaven | 11 maanden geleden
76 weergaven | 11 maanden geleden
![The importance of predicting venetoclax response in patients with AML [upl. by Whittemore]](img.php?img=imgidnIs2n-lzAh8)
Duration: 1:08
244 weergaven | 1 jaar geleden
244 weergaven | 1 jaar geleden
![Factors to consider when selecting JAK inhibitors for patients with MF [upl. by Artenra]](img.php?img=imgidbkcKhPDIE3g)
Duration: 2:23
113 weergaven | 14 sep. 2023
113 weergaven | 14 sep. 2023
![MAIC of momelotinib versus fedratinib safety in myelofibrosis [upl. by Grosmark]](img.php?img=imgidXKNgZnmw7BM)
Duration: 1:52
75 weergaven | 1 jaar geleden
75 weergaven | 1 jaar geleden
![ECOGE1910 study clinical benefit of early blinatumomab incorporation in ALL [upl. by Akieluz273]](img.php?img=imgidtJEj2xoGLc0)
Duration: 1:03
193 weergaven | 11 maanden geleden
193 weergaven | 11 maanden geleden
![Unmet needs in CML increasing treatmentfree remission amp accessibility to TKIs [upl. by Ardnuahc]](img.php?img=imgidTGgcI2KOQ5c)
Duration: 1:22
174 weergaven | 8 sep. 2023
174 weergaven | 8 sep. 2023
![Efficacy and safety of mosunetuzumab monotherapy for RR follicular lymphoma [upl. by Harley214]](img.php?img=imgidu-BDFJfN1Fw)
Duration: 1:12
292 weergaven | 11 maanden geleden
292 weergaven | 11 maanden geleden
![Advances in noncovalent BTK inhibitors for CLL BRUIN study update [upl. by Hairahcez]](img.php?img=imgid5pDwI2_oouo)
Duration: 0:48
136 weergaven | 12 sep. 2023
136 weergaven | 12 sep. 2023
![Flow cytometry in the diagnosis and management of chronic myeloid neoplasms [upl. by Julita]](img.php?img=imgidqJFu2NlmPbQ)
Duration: 1:47
158 weergaven | 21 sep. 2023
158 weergaven | 21 sep. 2023
![What physicians should know about genomic testing in AML [upl. by Veta]](img.php?img=imgidiIW4kTmFtZY)
![The role of BTK inhibitors in the frontline treatment of MCL [upl. by Nelon]](img.php?img=imgidnZXsAHuP3uE)
Duration: 1:15
43 weergaven | 2 weken geleden
43 weergaven | 2 weken geleden
![The impact of sequencing in AML [upl. by Merow552]](img.php?img=imgidJt7n3pqsU6U)
![An update on the OPTIC study adjusting the dose of ponatinib for CPCML [upl. by Audie]](img.php?img=imgidvwhVExzWV7Q)
Duration: 1:38
32 weergaven | 1 week geleden
32 weergaven | 1 week geleden
![Genomic profiling at diagnosis of myeloid neoplasms [upl. by Woodrow]](img.php?img=imgidVgeA4iPX1mI)
![Identifying highrisk DLBCL and optimizing treatment for these patients [upl. by Dedie636]](img.php?img=imgidUMA5MGvRiuE)
Duration: 1:05
64 weergaven | 1 week geleden
64 weergaven | 1 week geleden
![Moving towards a daratumumab standard of care in MM [upl. by Tilden]](img.php?img=imgidViBKeQwZ4Ds)
![A study investigating the impact of inherited variants on CLL prognosis [upl. by Berri]](img.php?img=imgidxZ7i1piERso)
Duration: 1:06
34 weergaven | 1 week geleden
34 weergaven | 1 week geleden
![Addressing unmet needs in myelofibrosis alleviating anemia [upl. by Alicec]](img.php?img=imgidzimw1JRjoEk)
Duration: 1:30
325 weergaven | 22 sep. 2023
325 weergaven | 22 sep. 2023
![MDS pathology recent advances and the role of the pathologist [upl. by Jahdal153]](img.php?img=imgidXfaEO8pozPg)
Duration: 4:37
1K weergaven | 14 sep. 2018
1K weergaven | 14 sep. 2018
![Current and emerging therapies for polycythemia vera [upl. by Avehsile]](img.php?img=imgidTdN6LnOFNcQ)
![The impact of prior therapies on the outcomes of patients with RR ALL treated with CART therapy [upl. by Attelliw67]](img.php?img=imgidFayTwUoMixQ)
Duration: 1:33
97 weergaven | 11 maanden geleden
97 weergaven | 11 maanden geleden
![Clinical significance of highcount MBL versus lowcount MBL [upl. by Olemrac]](img.php?img=imgid5HKWbby8X8I)
Duration: 3:40
344 weergaven | 21 sep. 2023
344 weergaven | 21 sep. 2023
![Elderly patients with HL unmet needs and promising strategies [upl. by Lavery511]](img.php?img=imgid4yM2-HYN_wA)
Duration: 2:52
127 weergaven | 21 sep. 2023
127 weergaven | 21 sep. 2023
![Emerging treatment options for lower and higherrisk MDS and ongoing trials [upl. by Ylac]](img.php?img=imgidEql6zdi2zzA)
Duration: 1:02
83 weergaven | 1 jaar geleden
83 weergaven | 1 jaar geleden
